{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:40:42Z","timestamp":1790732442753,"version":"4.1.0"},"reference-count":91,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Neurogenic and non-neurogenic urethral sphincter dysfunction are common causes of voiding dysfunction. Injections of botulinum toxin A (BoNT-A) into the urethral sphincter have been used to treat urethral sphincter dysfunction (USD) refractory to conventional treatment. Since its first use for patients with detrusor sphincter dyssynergia in 1988, BoNT-A has been applied to various causes of USD, including dysfunctional voiding, Fowler\u2019s syndrome, and poor relaxation of the external urethral sphincter. BoNT-A is believed to decrease urethral resistance via paralysis of the striated sphincter muscle through inhibition of acetylcholine release in the neuromuscular junction. Recovery of detrusor function in patients with detrusor underactivity combined with a hyperactive sphincter also suggested the potential neuromodulation effect of sphincteric BoNT-A injection. A large proportion of patients with different causes of USD report significant improvement in voiding after sphincteric BoNT-A injections. However, patient satisfaction might not increase with an improvement in the symptoms because of concomitant side effects including exacerbated incontinence, urinary urgency, and over-expectation. Nonetheless, in terms of efficacy and safety, BoNT-A is still a reasonable option for refractory voiding function. To date, studies focusing on urethral sphincter BoNT-A injections have been limited to the heterogeneous etiologies of USD. Further well-designed studies are thus needed.<\/jats:p>","DOI":"10.3390\/toxins11120728","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T11:27:22Z","timestamp":1576236442000},"page":"728","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction"],"prefix":"10.3390","volume":"11","author":[{"given":"Yao-Lin","family":"Kao","sequence":"first","affiliation":[{"name":"Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Hsun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi County 622, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":false,"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7934-4882","authenticated-orcid":false,"given":"Yin-Chien","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan"},{"name":"College of Medicine, Institute of Clinical Medicine, National Cheng Kung University, Tainan 704, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"ref_1","first-page":"S3","article-title":"Bladder outlet obstruction: Etiology and evaluation","volume":"7","author":"Dmochowski","year":"2005","journal-title":"Rev. Urol."},{"key":"ref_2","first-page":"127","article-title":"Detrusor sphincter dyssynergia: A review of physiology, diagnosis, and treatment strategies","volume":"5","author":"Stoffel","year":"2016","journal-title":"Transl. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/bmj.297.6661.1436","article-title":"Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: A new syndrome?","volume":"297","author":"Fowler","year":"1988","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/nau.23263","article-title":"Videourodynamic analysis of the urethral sphincter overactivity and the poor relaxing pelvic floor muscles in women with voiding dysfunction","volume":"36","author":"Peng","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0302-2838(03)00250-1","article-title":"Botulinum toxin as a new therapy option for voiding disorders: Current state of the art","volume":"44","author":"Leippold","year":"2003","journal-title":"Eur. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.21037\/tau.2016.12.05","article-title":"Use of botulinum toxin for voiding dysfunction","volume":"6","author":"Dasgupta","year":"2017","journal-title":"Transl. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tcmj.2016.07.001","article-title":"Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction","volume":"28","author":"Kuo","year":"2016","journal-title":"Tzu Chi Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/luts.12163","article-title":"Urethral Sphincter Injection of Botulinum Toxin A: A Review of Its Application and Outcomes","volume":"10","author":"Seth","year":"2018","journal-title":"Low. Urin. Tract Symptoms"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000060669","article-title":"Botulinum toxin: From poison to pharmaceutical. The history of a poison that became useful to mankind","volume":"30","author":"Kreyden","year":"2002","journal-title":"Curr. Probl. Dermatol."},{"key":"ref_11","unstructured":"Jankovic, J.H.M. (1994). Structures of botulinum neurotoxin, its functional domains, and perspectives on the cristalline type a toxin. Therapy with Botulinum Toxin, Marcel Dekker Inc."},{"key":"ref_12","unstructured":"Jankovic, J.H.M. (1994). Preparation and characterization of botulinum toxin type A for human treatment. Therapy with Botulinum Toxin, Marcel Dekker Inc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0019-5154.60343","article-title":"Botulinum toxin","volume":"55","author":"Nigam","year":"2010","journal-title":"Indian J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00007816","article-title":"Pharmacology and immunology of botulinum toxin serotypes","volume":"248","author":"Aoki","year":"2001","journal-title":"J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2011.07.001","article-title":"Contemporary management of lower urinary tract disease with botulinum toxin A: A systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)","volume":"60","author":"Mangera","year":"2011","journal-title":"Eur. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur. Urol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/0929867053363315","article-title":"Management of bladder, prostatic and pelvic floor disorders with botulinum neurotoxin","volume":"12","author":"Maria","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2710.2007.00835.x","article-title":"Comparing two botulinum toxin type A formulations using manufacturers\u2019 product summaries","volume":"32","author":"Wenzel","year":"2007","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0301-0082(98)00070-7","article-title":"Bladder afferent pathway and spinal cord injury: Possible mechanisms inducing hyperreflexia of the urinary bladder","volume":"57","author":"Yoshimura","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2006.01.005","article-title":"Botulinum toxin--new mechanisms, new therapeutic directions?","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Moore, D.C., Cohn, J.A., and Dmochowski, R.R. (2016). Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature. Toxins, 8.","DOI":"10.3390\/toxins8040088"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Jhang, J.F., and Kuo, H.C. (2016). Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action. Toxins, 8.","DOI":"10.3390\/toxins8040120"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/01.ju.0000049202.56189.54","article-title":"Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract","volume":"169","author":"Smith","year":"2003","journal-title":"J. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2006.08.1117","article-title":"Recovery of detrusor function after urethral botulinum a toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction","volume":"69","author":"Kuo","year":"2007","journal-title":"Urology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/003655901750174872","article-title":"Neural control of the urethra","volume":"35","author":"Fraser","year":"2001","journal-title":"Scand. J. Urol. Nephrol. Suppl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.juro.2012.04.011","article-title":"The possible role of opiates in women with chronic urinary retention: Observations from a prospective clinical study","volume":"188","author":"Panicker","year":"2012","journal-title":"J. Urol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0022-5347(17)55099-5","article-title":"Detrusor-external sphincter dyssynergia","volume":"125","author":"Blaivas","year":"1981","journal-title":"J. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0022-5347(17)54147-6","article-title":"The neurophysiology of micturition: A clinical study of 550 patients","volume":"127","author":"Blaivas","year":"1982","journal-title":"J. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0090-4295(99)00553-1","article-title":"Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury","volume":"55","author":"Weld","year":"2000","journal-title":"Urology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jnnp.73.2.154","article-title":"Bladder dysfunction in acute transverse myelitis: Magnetic resonance imaging and neurophysiological and urodynamic correlations","volume":"73","author":"Kalita","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0022-5347(01)61760-9","article-title":"Multiple sclerosis and the urologist","volume":"161","author":"Litwiller","year":"1999","journal-title":"J. Urol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1352458506075651","article-title":"The neurogenic bladder in multiple sclerosis: Review of the literature and proposal of management guidelines","volume":"13","author":"Ruffion","year":"2007","journal-title":"Mult. Scler."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0022-5347(17)37254-3","article-title":"Risk factors for upper tract deterioration in chronic spinal cord injury patients","volume":"147","author":"Gerridzen","year":"1992","journal-title":"J. Urol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/01.ju.0000084623.65480.f8","article-title":"Tamsulosin: Efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury","volume":"170","author":"Abrams","year":"2003","journal-title":"J. Urol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/nau.1930140109","article-title":"Non-operative management of the urinary tract in spinal cord injury","volume":"14","author":"Dmochowski","year":"1995","journal-title":"Neurourol. Urodyn."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/nau.1930140106","article-title":"External urethral sphincterotomy: Long-term follow-up","volume":"14","author":"Yang","year":"1995","journal-title":"Neurourol. Urodyn."},{"key":"ref_38","first-page":"639","article-title":"Management of detrusor external sphincter dyssynergia in neurogenic bladder","volume":"47","author":"Mahfouz","year":"2011","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"ref_39","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum a toxin: A double-blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","article-title":"Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: A prospective study in 24 spinal cord injury patients","volume":"155","author":"Schurch","year":"1996","journal-title":"J. Urol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.sc.3100517","article-title":"Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease","volume":"36","author":"Petit","year":"1998","journal-title":"Spinal Cord"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-5347(05)66438-5","article-title":"Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction","volume":"165","author":"Phelan","year":"2001","journal-title":"J. Urol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0302-2838(02)00209-9","article-title":"Botulinum a toxin and detrusor sphincter dyssynergia: A double-blind lidocaine-controlled study in 13 patients with spinal cord disease","volume":"42","author":"Petit","year":"2002","journal-title":"Eur. Urol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","article-title":"Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients","volume":"76","author":"Gallien","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/sc.2015.224","article-title":"Predictors of outcome for urethral injection of botulinum toxin to treat detrusor sphincter dyssynergia in men with spinal cord injury","volume":"54","author":"Soler","year":"2016","journal-title":"Spinal Cord"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.apmr.2008.10.023","article-title":"Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: Localization with combined fluoroscopic and electromyographic guidance","volume":"90","author":"Tsai","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.apmr.2009.11.006","article-title":"Transrectal ultrasound-guided transperineal botulinum toxin a injection to the external urethral sphincter for treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury","volume":"91","author":"Chen","year":"2010","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/01.ju.0000091281.50081.f0","article-title":"Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction","volume":"170","author":"Kuo","year":"2003","journal-title":"J. Urol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","article-title":"Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra","volume":"65","author":"Smith","year":"2005","journal-title":"Urology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2340\/16501977-0255","article-title":"Effect of single botulinum toxin A injection to the external urethral sphincter for treating detrusor external sphincter dyssynergia in spinal cord injury","volume":"40","author":"Chen","year":"2008","journal-title":"J. Rehabil. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/nau.20606","article-title":"Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion","volume":"27","author":"Kuo","year":"2008","journal-title":"Neurourol. Urodyn."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/ijcp.12152","article-title":"Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia","volume":"67","author":"Kuo","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2340\/16501977-2132","article-title":"Effects of botulinum toxin A injections in spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia","volume":"48","author":"Huang","year":"2016","journal-title":"J. Rehabil. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1016-3190(10)60005-5","article-title":"Comparison of the Therapeutic Effects of Urethral Injections of 50 and 100 Units of Botulinum A Toxin for Voiding Dysfunction","volume":"19","author":"Kuo","year":"2007","journal-title":"Tzu Chi Med. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.urology.2007.06.1083","article-title":"Causes of failed urethral botulinum toxin a treatment for emptying failure","volume":"70","author":"Liao","year":"2007","journal-title":"Urology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/nau.22751","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children\u2019s Continence Society","volume":"35","author":"Austin","year":"2016","journal-title":"Neurourol. Urodyn."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-5347(17)60526-3","article-title":"Vesical and ureteral damage from voiding dysfunction in boys without neurologic or obstructive disease","volume":"109","author":"Hinman","year":"1973","journal-title":"J. Urol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0022-5347(17)58412-8","article-title":"The non-neurogenic neurogenic bladder","volume":"117","author":"Allen","year":"1977","journal-title":"J. Urol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0022-5347(17)45077-4","article-title":"Nonneurogenic neurogenic bladder (the Hinman syndrome)--15 years later","volume":"136","author":"Hinman","year":"1986","journal-title":"J. Urol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/nau.1003","article-title":"Learned voiding dysfunction (non-neurogenic, neurogenic bladder) among adults","volume":"20","author":"Groutz","year":"2001","journal-title":"Neurourol. Urodyn."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4103\/0970-1591.91429","article-title":"Dysfunctional voiding: A review of the terminology, presentation, evaluation and management in children and adults","volume":"27","author":"Sinha","year":"2011","journal-title":"Indian J. Urol. IJU J. Urol. Soc. India"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.juro.2009.12.059","article-title":"The management of dysfunctional voiding in children: A report from the Standardisation Committee of the International Children\u2019s Continence Society","volume":"183","author":"Chase","year":"2010","journal-title":"J. Urol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/01.ju.0000138872.14641.40","article-title":"Improved uroflow parameters and post-void residual following biofeedback therapy in pediatric patients with dysfunctional voiding does not correspond to outcome","volume":"172","author":"Nelson","year":"2004","journal-title":"J. Urol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0022-5347(01)68067-4","article-title":"alpha-Adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction","volume":"162","author":"Austin","year":"1999","journal-title":"J. Urol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00005392-199707000-00067","article-title":"Botulinum toxin: Novel treatment for dramatic urethral dilatation associated with dysfunctional voiding","volume":"158","author":"Steinhardt","year":"1997","journal-title":"J. Urol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.juro.2006.03.119","article-title":"Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder","volume":"176","author":"Mokhless","year":"2006","journal-title":"J. Urol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.juro.2007.03.185","article-title":"The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children","volume":"178","author":"Franco","year":"2007","journal-title":"J. Urol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.juro.2013.10.034","article-title":"Long-term efficacy and durability of botulinum-A toxin for refractory dysfunctional voiding in children","volume":"191","author":"Vricella","year":"2014","journal-title":"J. Urol."},{"key":"ref_69","first-page":"119","article-title":"Breaking the vicious circle: Onabotulinum toxin A in children with therapy-refractory dysfunctional voiding","volume":"11","author":"Wolffenbuttel","year":"2015","journal-title":"J. Pediatric Urol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.juro.2007.08.027","article-title":"Botulinum toxin type A in combination with standard urotherapy for children with dysfunctional voiding","volume":"178","author":"Petronijevic","year":"2007","journal-title":"J. Urol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"38905","DOI":"10.1038\/srep38905","article-title":"OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction\u2014A Randomized, Double-Blind, Placebo-Controlled Study","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.5489\/cuaj.5230","article-title":"Dysfunctional voiding: Challenges of disease transition from childhood to adulthood","volume":"12","author":"Morin","year":"2018","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/nau.23897","article-title":"The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction","volume":"38","author":"Haylen","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_74","first-page":"402","article-title":"Dry needling for myofascial trigger point pain: A clinical commentary","volume":"10","author":"Unverzagt","year":"2015","journal-title":"Int. J. Sports Phys."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(86)91497-2","article-title":"Electromyography of urethral sphincter in women with urinary retention","volume":"1","author":"Fowler","year":"1986","journal-title":"Lancet (Lond. Engl.)"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/01.ju.0000113201.26176.8f","article-title":"Urodynamic study of women in urinary retention treated with sacral neuromodulation","volume":"171","author":"DasGupta","year":"2004","journal-title":"J. Urol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrurol.2013.277","article-title":"Fowler\u2019s syndrome\u2014A cause of unexplained urinary retention in young women?","volume":"11","author":"Osman","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol. Urodyn."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1464-410X.1992.tb15793.x","article-title":"Botulinum toxin in the treatment of chronic urinary retention in women","volume":"70","author":"Fowler","year":"1992","journal-title":"Br. J. Urol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/bju.13342","article-title":"Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler\u2019s syndrome)","volume":"117","author":"Panicker","year":"2016","journal-title":"BJU Int."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Lee, Y.K., and Kuo, H.C. (2019). Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions. Toxins, 11.","DOI":"10.3390\/toxins11090487"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000030497","article-title":"Pathophysiology of lower urinary tract symptoms in aged men without bladder outlet obstruction","volume":"64","author":"Kuo","year":"2000","journal-title":"Urol. Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/luts.12067","article-title":"Role of Bladder Neck and Urethral Sphincter Dysfunction in Men with Persistent Bothersome Lower Urinary Tract Symptoms after alpha-1 Blocker Treatment","volume":"7","author":"Ke","year":"2015","journal-title":"Low. Urin. Tract Symptoms"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000048427","article-title":"Analysis of the pathophysiology of lower urinary tract symptoms in patients after prostatectomy","volume":"68","author":"Kuo","year":"2002","journal-title":"Urol. Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1038\/s41598-017-07163-2","article-title":"Videourodynamic Studies of Women with Voiding Dysfunction","volume":"7","author":"Hsiao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/luts.12187","article-title":"Role of poor urethral sphincter relaxation in men with voiding dysfunction refractory to alpha-blocker therapy: Clinical characteristics and predictive factors","volume":"11","author":"Shao","year":"2019","journal-title":"Low. Urin. Tract Symptoms"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1742-1241.2011.02638.x","article-title":"Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms","volume":"65","author":"Liao","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/nau.23542","article-title":"Videourodynamic characteristics of interstitial cystitis\/bladder pain syndrome-The role of bladder outlet dysfunction in the pathophysiology","volume":"37","author":"Kuo","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.urology.2007.03.063","article-title":"Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms","volume":"70","author":"Kuo","year":"2007","journal-title":"Urology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/luts.12139","article-title":"Role of Bladder Dysfunction in Men with Lower Urinary Tract Symptoms Refractory to Alpha-blocker Therapy: A Video-urodynamic Analysis","volume":"10","author":"Jiang","year":"2018","journal-title":"Low. Urin. Tract Symptoms"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Jiang, Y.H., and Kuo, H.C. (2017). Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men\u2014A comparison of men with normal tracing and bladder outlet obstruction. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174593"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/11\/12\/728\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:42:00Z","timestamp":1760190120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/11\/12\/728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":91,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["toxins11120728"],"URL":"https:\/\/doi.org\/10.3390\/toxins11120728","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]}}}